BigHat Biosciences Stock

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Sign up today and learn more about BigHat Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BigHat Biosciences Stock

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.


Funding History

December 2019$5.3M
February 2021$19.0M


Co-Founder and CEO

Mark DePristo

Co-Founder and CSO

Peyton Greenside

Chief Business Officer

Liz Schwarzbach

Vice President Of Engineering

Ed Abrams

Board of Director

Vineeta Agarwala

Director Board of Directors

Francisco Gimenez

Founding Advisor

Theresa Tribble


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: